Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men

• William D. Finkle ,

  * E-mail: hooverr@mail.nih.gov (RNH); bill@consolidated-research.com (WDF)

  Affiliation Consolidated Research, Inc., Los Angeles, California, United States of America

  ⨯
• Sander Greenland,

  Affiliation Department of Epidemiology and Department of Statistics, University of California, Los Angeles, California, United States of America

  ⨯
• Gregory K. Ridgeway,

  Affiliation Consolidated Research, Inc., Los Angeles, California, United States of America

  ⨯
• John L. Adams,

  Affiliation Consolidated Research, Inc., Los Angeles, California, United States of America

  ⨯
• Melissa A. Frasco,

  Affiliation Consolidated Research, Inc., Los Angeles, California, United States of America

  ⨯
• Michael B. Cook,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Joseph F. Fraumeni Jr,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Robert N. Hoover

  * E-mail: hooverr@mail.nih.gov (RNH); bill@consolidated-research.com (WDF)

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯